Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
01/2008
01/02/2008CN101098851A Beta-alkoxypropionamide compound, solvent, detergent, liquid pharmaceutical composition, and process for producing beta-alkoxypropionamide compound
01/01/2008US7314957 N-Optionally substituted methylol derivatives of naphthalene- and biphenylene- dicarboxamides; monomers for heat resistant polyesters, polyamides, polyurethanes and liquid crystal polymers.
01/01/2008US7314955 Crystalline form "C"; amidating D-phenylalanine methyl ester hydrocholoride with trans-4-isopropylcyclohexane carboxylic acid in a halogenated hydrocarbon; hydrolyzing to form free acid
01/01/2008US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1
01/01/2008US7314639 Process for the production of crystals of a benzoic acid derivative
12/2007
12/27/2007WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative
12/27/2007WO2007147839A1 Glycine transporter inhibiting compounds and uses in medicine
12/27/2007WO2007147836A1 Glycine transporter inhibiting compounds and uses in medicine
12/27/2007WO2007147252A1 Ship 1 modulator prodrugs
12/27/2007US20070299263 Hydroxy Alkyl Amines
12/27/2007US20070299137 N-Acylated Derivatives Of Dicarboxylic Acids With Amino Acids And Vegetable Protein Hydrolsates And Their Use In Cosmetics And Pharmaceuticals
12/27/2007US20070299136 Crystalline and Amorphous Forms of Efaproxiral Sodium
12/27/2007US20070299080 Benzamide derivatives and uses related thereto
12/27/2007US20070298968 2,4,6-Phenyl-Substituted Cyclic Ketoenols
12/27/2007CA2656339A1 Ship 1 modulator prodrugs
12/26/2007EP1870396A1 Benzyloxypropylamine derivative
12/26/2007CN101094830A Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation
12/26/2007CN101094829A Novel anthranilic acid derivative or salt thereof
12/26/2007CN101094827A Benzene compound having two or more substituents
12/26/2007CN101092375A Compound of amide diketone acid, preparation method and application
12/25/2007US7312368 Reacting halogen and hydroxy substituted aromatic compounds with an alkali metal or in a nitrogen base and an alcohol; hydroxyl group prevents dehalogenation; selectively retaining a halogen group on an aromatic ring
12/21/2007WO2007144981A1 Benzylidene malonamide and salt thereof, ultraviolet ray absorbent, and agent for external application to the skin
12/21/2007WO2007144639A1 2 -oxybenzamide derivatives as parp inhibitors
12/21/2007WO2007115269A3 Orally bioavailable caffeic acid related anticancer drugs
12/21/2007CA2655146A1 Benzamide derivatives and uses related thereto
12/20/2007US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
12/20/2007US20070293483 Acetyl 2-hydroxy-1, 3-diaminoalkanes
12/19/2007EP1867633A1 Polyamine analogues as therapeutic and diagnostic agents
12/19/2007EP1867629A2 Method for producing naphthalene carboxylic acid amide compound
12/19/2007EP1866279A2 Alkylated and polymeric macromolecular antioxidants and methods of making and using the same
12/19/2007EP1866276A1 Alpha ketoamide compounds as cysteine protease inhibitors
12/19/2007EP1701946B1 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
12/19/2007EP1497261B1 Phenethanolamine derivatives
12/19/2007EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007CN101090641A Process for preparing maillard flavour preparations
12/19/2007CN101088987A Method for producing naphthalene carboxylic acid amide compound
12/19/2007CN100355823C Conversion products of mixtures of long-chained fatty acids and aliphatic diamines, and the use thereof
12/18/2007US7309698 Compositions for delivering bisphosphonates
12/13/2007WO2007141423A1 Ppar enhancing derivatives, method for preparing same and therapeutic use thereof
12/13/2007US20070287840 Process for Preparing Telmisartan
12/13/2007US20070287751 Therapy for obesity; using a secondary amino compound
12/13/2007DE19756888B4 Reversibles wärmeempfindliches Aufzeichnungsmaterial, Verfahren zur Herstellung, Aufzeichnungsverfahren und Beschichtungsflüssigkeit A reversible thermosensitive recording material, methods of making, recording method, and the coating liquid
12/12/2007CN101085747A Method for preparing N-methyl-malonamic acid ethyl ester
12/12/2007CN101085746A Method for preparing N-(4-ethoxyphenyl)-2-hydroxybenzamide compound
12/12/2007CN100354253C 5,8-menadiol diacetate derivatives and their preparing process and use
12/11/2007US7307078 Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
12/06/2007WO2007137925A1 Hydroxylated amide skin moisturizer
12/06/2007WO2007137410A1 Biomarkers for diagnosing multiple sclerosis, and methods thereof
12/06/2007WO2007100351A3 Process for preparing simvastatin and intermediates thereof
12/06/2007WO2007074386A9 A novel process for synthesis of itopride and it’s novel intermediate-n-(4-hydroxybenzyl)-3,4-dimethoxybenzamide
12/06/2007US20070282002 N-lauroyl-L-valine, as therapeutic agent of metabolic syndromes, hypoadiponectinemia, hyperlipemia, diabetes, hypertension, cardiovascular disorders, liver disoders, obesity, as an antiinflammatory agent, improving agent of impaired glucose tolerance, insulin resistance and insulin sensitivity
12/06/2007US20070281991 Preparation Of Phenol-Amide Compounds With Anti-Oxidizing Properties
12/06/2007US20070281954 Cyclohexyl-1,4-diamine compounds
12/06/2007DE19936626B4 Resistentfernungsmittel und Resistentfernungsverfahren Resist remover and resist removal method
12/06/2007CA2651724A1 Biomarkers for diagnosing multiple sclerosis, and methods thereof
12/05/2007EP1862455A2 11-((4R,6R)-4,5,6-trihydroxy-3-(R)-hydroxy-2-(S)-hydroxy-hexylcarbamoyl)-undecanoic acid
12/05/2007EP1862451A1 Adamantane derivatives for the treatment of inflammatory diseases
12/05/2007EP1862450A2 Novel compounds
12/05/2007EP1784384A4 Process for preparation of 4-fluoro-alpha-[2-methyl-1-oxopropyl]gamma-oxo-n-beta-diphenylbenzene butane amide
12/05/2007CN101084178A (benzyloxy-biphenyl) acetic acids and derivatives thereof
11/2007
11/29/2007WO2007135541A1 11c-labeled benzophenone/benzoxazole analogues as an inflammation imaging agent
11/29/2007WO2007114855A3 Glucagon receptor antagonists, preparation and therapeutic uses
11/29/2007WO2007092190A3 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
11/29/2007US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007US20070276041 Ppar activity regulators
11/29/2007US20070275436 polypeptide comprising an amino acid sequence having polyene polyketide synthase activity; involved in the biosynthesis of novel polyketides, inhibitors of fungal cell growth and cancer cell growth
11/28/2007EP1858836A1 Analogues of the azinomycins as anti-tumour agents and as prodrugs
11/28/2007CN101080384A Manufacture process of N-substituted salicylamide
11/28/2007CN101080383A Tri (hydroxymethyl) methylamine salt or an ethanol amine salt of (2S) -2-ethoxy-3- (4-{2- [hexyl (2- phenylethyl) amino] - 2 -oxoethoxy} phenyl) propanoic acid
11/28/2007CN101080382A Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use
11/28/2007CN101080381A Manufacture process of n-substituted salicylamides
11/27/2007US7300917 Remedy for chronic disease
11/27/2007US7300756 for covalent attachment of target molecules (nucleic acids) onto substrate; for production of activated slides for use in preparing microarrays; solid phase synthesis
11/27/2007CA2299710C Aryloxyaniline derivatives
11/22/2007WO2007131996A1 Meta-xylylenediamine vanadate salts
11/22/2007US20070270482 Cytotoxic Agents Comprising New C-2 Modified Taxanes
11/21/2007EP1856031A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
11/21/2007EP1856030A2 Structural analogues of avenanthramides, their use in compositions useful in the treatment of dermatological disorders
11/21/2007EP1585752B1 Polyene polyketides, processes for their production and their use as a pharmaceutical
11/21/2007EP1385498B1 Fatty acids as neutrophil survival and activation factors.
11/21/2007CN100349872C Method for producing amine derivative
11/20/2007US7297818 Adamantane derivatives
11/15/2007WO2007129729A1 Process for production of fish-derived ceramide, and ceramide-containing composition
11/15/2007WO2007056469A3 Certain chemical entities, compositions, and methods
11/15/2007US20070265323 Compounds for the treatment of metabolic disorders
11/15/2007US20070265322 Compounds for the treatment of metabolic disorders
11/15/2007US20070265268 inhibiting heat shock protein 90 (Hsp90) family protein comprising administering benzoic acid derivatives or prodrugs, for the treatment of breast cancer or leukemia
11/15/2007US20070265228 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis
11/15/2007US20070264217 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners
11/14/2007EP1854782A1 Taste improving composition
11/14/2007EP1853578A1 Substituted tetralins as selective estrogen receptor-beta agonists
11/14/2007EP1853555A1 Anthranilic acid derivatives active at the hm74a receptor
11/14/2007EP1853554A2 Alpha, omega-difunctional aldaramides
11/14/2007EP1853538A2 Modulator
11/14/2007EP1492762B1 Photostable cationic organic sunscreen compounds with antioxidant properties and compisitions obtained therefrom
11/14/2007EP1381355B1 Use of rhein and its derivatives as matrix metalloproteinase inhibitors
11/14/2007CN101072561A Diaminoalkane aspartic protease inhibitors
11/14/2007CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/14/2007CN100348569C Induction of apoptosis in cancer cells
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 157